Mar 24, 2026 by Seena HassounaIcahn Enterprises Just Added $78 Million in Centuri Shares, but the Real Story Starts EarlierCenturi Holdings delivers utility infrastructure services to regulated gas and electric providers across North America.
Mar 21, 2026 by Seena HassounaBristow Group's CFO Just Sold $1.2 Million in Stock — But Is That the Whole Equation?Bristow Group, a global aviation services provider to offshore energy firms, reported a notable insider sale in its latest SEC filing.
Mar 21, 2026 by Seena HassounaENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to WatchThis clinical-stage biotech develops immunology therapies for autoimmune and inflammatory diseases, with a diverse pipeline underway.
Mar 20, 2026 by Seena HassounaOaktree Knows Distressed Debt. Its Garrett Motion Sale Tells You Something.Garrett Motion designs turbochargers and electric-boosting systems for global automotive manufacturers and aftermarket distributors.
Mar 19, 2026 by Seena HassounaNextech Trims Kymera at a Recent High — think Foolishly before acting.Kymera Therapeutics develops targeted protein degradation therapies for immunology and oncology, advancing a diversified clinical pipeline.
Mar 18, 2026 by Seena HassounaSignal or Noise: What VR Adviser's Spyre Theraputics Buy MeansSpyre Therapeutics focuses on antibody therapies for inflammatory bowel disease, advancing a pipeline aimed at gastrointestinal health.
Mar 18, 2026 by Seena HassounaAtriCure CSO Sells 5,000 Shares — A Modest Trim or a Pattern Worth Watching?This medical device innovator for cardiac surgery reported a notable insider sale amid a year of negative total returns.
Mar 18, 2026 by Seena HassounaWhat to Make of VR Adviser's Big Ocular Therapeutix Sell-DownThis ophthalmic biopharma firm develops sustained drug delivery therapies for eye diseases, targeting both U.S. and global markets.
Mar 17, 2026 by Seena HassounaWhat's Behind Naspers's Steady Exit From Remitly?Remitly, a global digital remittance provider, saw significant insider selling as disclosed in recent regulatory filings.
Mar 15, 2026 by Seena HassounaISCG vs. RZG: Which Small-Cap Growth ETF Fits Your Portfolio?Expense ratios, sector tilts, and portfolio breadth set these two small-cap growth ETFs apart for investors weighing their options.
Mar 15, 2026 by Seena HassounaCBIZ Insider Sale: Trust Move or Warning Sign?CBIZ, Inc., a major business services provider, reported significant insider selling amid a year of sharp share price declines.
Mar 15, 2026 by Seena HassounaA Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you?This clinical-stage biotech develops antibody therapies targeting autoimmune diseases, with a lead candidate in Phase II trials.
Mar 13, 2026 by Seena HassounaA Hedge Fund Just Trimmed $2.7 Million of NCR Voyix. Should You Care?NCR Voyix delivers technology and managed services across retail, hospitality, and financial services for enterprise clients worldwide.
